Dr. Peter Doshi: "What's Under the Hood of Pfizer Clinical Trials Is Not Science - It's Business"

Dr. Peter Doshi, Sr. Editor at the BMJ, speaks a second time at the "Real, Not Rare" rally testimonies in Washington, DC on 11/2/21. He explains the trials have still not ended, and we will not be able to get information on the trials until late 2022, and that "data secrecy" has become the norm.